Regis Technologies aces recent FDA inspections
US FDA audits are a lot tougher than customer inspections according to CMO Regis, which has just passed two agency assessments with no 483 observations.
Archives for January 23, 2014
Confusion over lethal injection drug shortage status
The contentious drug Midazolam is no longer in short supply, the FDA has told In-PharmaTechnologist.com.
Hospira intent on growing Indian ops as EU market beckons
Increased in-house API production and manufacturing in India will lower the costs of Hospira’s injectables, the firm says, as it looks past current remediation efforts.
Cost and compliance turning CROs to outsourced site payment providers
The need to improve efficiency and comply with regulatory and geographical demands is driving the third-party clinical payment industry, say Greenphire, CFS and Clinverse.
Rexam opens extension at French nasal pump plant
Rexam has completed its extension of a French plant that manufactures the nasal spray pump product, Advancia.
Hopkinton phasedown hits Lonza's 2013 sales
Higher earnings and improved margins did not impress investors in Lonza, which saw its share price tumble today after revealing that sales to the drug sector fell in 2013.